KANSAS CITY, Mo. and MENLO PARK, Calif. — Pacific Biosciences of California, Inc. (Nasdaq: PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that Children’s Mercy Kansas City, one of the nation’s top pediatric medical centers, has increased its investment in highly accurate HiFi sequencing with four new Sequel IIe Systems to add […]
— Studying Methylation Patterns Provides Unique Insight into Disease Pathology — — System Improves Accuracy of Results, Allows Capture of Customized Genes of Interest, Operational Efficiency — SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today […]
Liquid biopsy-based precision test guides patient selection and offers potential for cost-effective, non-invasive alternative to surgical removal of cervical lesions First-in-class next generation sequencing (NGS) assay designed for use on Illumina NextSeq™ 550Dx PLYMOUTH MEETING, PA., USA, and GERMANTOWN, MD., USA, and HILDEN, Germany – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and INOVIO Pharmaceuticals (NASDAQ: INO) today announced an […]
Project Underscores Growing Importance of Efficient Genomic Data Management, Visibility and Retrieval BOSTON – Seven Bridges, the industry-leading bioinformatics ecosystem provider, is supporting Pfizer Inc. (NYSE: PFE) in the development of a data management and collaboration solution for the biopharmaceutical company’s single-cell ribonucleic acid (RNA) sequencing (scRNASeq) data. The Seven Bridges Platform is a cloud-based […]
Acquires Tetramer Shop; Reveals Details on Upcoming Products PLEASANTON, Calif. — 10x Genomics, Inc. (Nasdaq: TXG) today detailed a slew of new products and announced the acquisition of Copenhagen-based Tetramer Shop at its inaugural Xperience 2021 event, a showcase with three breakout sessions corresponding to 10x’s three product platforms: Chromium Single Cell, Visium Spatial, and In […]
Funding by CVC Credit has supported five acquisitions since June 2020 CVC Credit is pleased to announce that it has further supported life sciences and diagnostics business, Calibre Scientific, by leading an incremental $57 million multicurrency first lien credit facility to help fuel its ongoing global acquisition strategy. Calibre Scientific is owned by investment firm […]
G+FLAS Life Sciences is applying CRISPR technology to develop research tools and reagents Dublin, Ireland and Seoul, Korea: ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, and G+FLAS Life Sciences, Inc. (G+FLAS), a biotechnology company developing research tools and reagents associated with CRISPR […]
PARIS and SOUTH SAN FRANCISCO, Calif.: DNA Script, SAS, a leading pioneer in enabling DNA synthesis on demand, and baseclick GmbH announced today an exclusive licensing agreement that grants DNA Script use of the novel “Click” chemistry commercialized by baseclick. In effect, this agreement enables DNA Script’s customers to enzymatically synthesize high purity nucleic acids […]
SEATTLE — Phase Genomics, Inc., the biotech leader providing proximity-ligation solutions for the genomics community, announced today the receipt of a $1.7MM grant from the National Institute of Allergy and Infectious Diseases (NIAID). This funding will fuel the commercialization of a first-in-class solution for the discovery of DNA viruses, employing a novel reagent kit and […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Berry Genomics, a leading commercial next-generation sequencing (NGS) provider in China, will add Twist’s NGS target enrichment and library preparation tools to its offering. The […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
